Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,500 shares at $274.54 ($417K) on 2021-12-14, disclosed to the SEC on 2021-12-16.
Open-market sale of $417k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $274.54 | 300 | $82K | 19.7% |
| 2 | $276.95 | 300 | $83K | 19.9% |
| 3 | $278.21 | 500 | $139K | 33.3% |
| 4 | $278.79 | 100 | $28K | 6.7% |
| 5 | $281.64 | 200 | $56K | 13.5% |
| 6 | $284.52 | 100 |
| $28K |
| 6.8% |
| Total | $278.14 avg | 1,500 | $417K | 100% |
| Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |
| BGNE | SELL | 2021-09-22 | $3.6M | — | Filing → |